The Investment Case for Preventing NICU-Associated Infections

Abstract Background Nosocomial [hospital-associated or neonatal intensive care unit (NICU)-associated] infections occur in as many as 10 to 36% of very low-birth-weight infants cared for in NICUs. Objective To determine the potentially avoidable, incremental costs of care associated with NICU-associated bloodstream infections. Study Design This retrospective study included all NICU admissions of infants weighing 401 to 1500 g at birth in the greater Cincinnati region from January 1, 2005, through December 31, 2007. Nonphysician costs of care were compared between infants who developed at least one bacterial bloodstream infection prior to NICU discharge or death and infants who did not. Costs were adjusted for clinical and demographic characteristics that are present in the first 3 days of life and are known associates of infection. Results Among 900 study infants with no congenital anomaly and no major surgery, 82 (9.1%) developed at least one bacterial bloodstream infection. On average, the cost of NICU care was $16,800 greater per infant who experienced NICU-associated bloodstream infection. Conclusion Potentially avoidable costs of care associated with bloodstream infection can be used to justify investments in the reliable implementation of evidence-based interventions designed to prevent these infections.

[1]  M. Walsh,et al.  Ohio Statewide Quality-Improvement Collaborative to Reduce Late-Onset Sepsis in Preterm Infants , 2011, Pediatrics.

[2]  S. Saleh,et al.  The Cost Impact of Hospital-Acquired Conditions Among Critical Care Patients , 2010, Medical care.

[3]  A. Torbica,et al.  Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy , 2010, Cost effectiveness and resource allocation : C/E.

[4]  M. Kilgore,et al.  Cost of bloodstream infections. , 2008, American journal of infection control.

[5]  N. Graves,et al.  Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis. , 2008, Journal of advanced nursing.

[6]  T. Jackson,et al.  Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004. , 2008, The Journal of hospital infection.

[7]  J. Stockwell.  Nosocomial infections in the pediatric intensive care unit: Affecting the impact on safety and outcome , 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[8]  Richard P Shannon,et al.  Economics of Central Line-Associated Bloodstream Infections , 2006, American journal of medical quality : the official journal of the American College of Medical Quality.

[9]  C. Hollenbeak,et al.  Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital* , 2006, Critical care medicine.

[10]  B. Manns,et al.  Cost of intensive care unit-acquired bloodstream infections. , 2006, The Journal of hospital infection.

[11]  S. Ponce de León Rosales,et al.  The burden of nosocomial infection in the intensive care unit: Effects on organ failure, mortality and costs. A nested case-control study. , 2006, Archives of medical research.

[12]  P. Chou,et al.  Impact of Nosocomial Infection on Cost of Illness and Length of Stay in Intensive Care Units , 2005, Infection Control & Hospital Epidemiology.

[13]  G. Badger,et al.  Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. , 2004, Pediatrics.

[14]  F. Azzeri,et al.  Cost evaluation of patients with severe sepsis in intensive care units. , 2004, Minerva anestesiologica.

[15]  B. Stoll,et al.  Infections in VLBW infants: studies from the NICHD Neonatal Research Network. , 2003, Seminars in perinatology.

[16]  W. Trick,et al.  The use of economic modeling to determine the hospital costs associated with nosocomial infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Victoria J. Fraser,et al.  Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* , 2003, Critical care medicine.

[18]  Sheila Leatherman,et al.  The business case for quality: case studies and an analysis. , 2003, Health affairs.

[19]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[20]  G. B. Orsi,et al.  Hospital-Acquired, Laboratory-Confirmed Bloodstream Infection: Increased Hospital Stay and Direct Costs , 2002, Infection Control & Hospital Epidemiology.

[21]  P. Beutels,et al.  Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. , 2001, The Journal of hospital infection.

[22]  J D Horbar,et al.  Economic implications of neonatal intensive care unit collaborative quality improvement. , 2001, Pediatrics.

[23]  S. Finkler.  Cost Accounting for Health Care Organizations: Concepts and Applications , 1999 .

[24]  E. Bingen,et al.  Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit. , 1997, The Journal of hospital infection.